StreetAlpha.app
Home › Stocks › HAE

Haemonetics Corp (HAE)

Healthcare
$120.16
▼ −0.17%
LAST CLOSE · NOV 20

Haemonetics makes plasma collection devices, blood processing equipment and hospital products for plasma centers, blood centers and hospitals. It last closed at $120.16 on Nov 20, down 0.17% on the day. The next earnings report for HAE is expected around Thu, Feb 4, 2027. For the quarter ended Sep 2026, HAE reported EPS of $1.00 on revenue of $357.8M, with revenue up 9.3% from a year ago. Over its last 8 reports the stock moved an average of 10.7% the session after earnings. Over the last 12 months HAE insiders bought $0 of stock on the open market and sold $101K, according to SEC Form 4 filings.

AI Auto Pilots
Is HAE in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold HAE.

Key Stats

Last 12 months
Results
Revenue
$1.4B
+4.1% vs a year ago
Net income
$103.9M
−38.2% vs a year ago
EPS (diluted)
$2.26
−33.9% vs a year ago
Free cash flow
$298.2M
21.6% margin
Valuation
Market cap
$5.5B
45.5M shares
P/E
53.2
Price over 12 month EPS
Price to sales
4.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$260.7M
At Sep 26
Debt
$1.1B
At Sep 26
Shareholder equity
$898.5M
Buybacks
$100.0M
Last 12 months
Fiscal year endsApril
ExchangeNYSE
Financials history
FY2022: $993.2M$993.2MFY2022FY2023: $1.2B$1.2BFY2023FY2024: $1.3B$1.3BFY2024FY2025: $1.4B$1.4BFY2025FY2026: $1.3B$1.3BFY2026

From HAE's SEC filings, latest 10-Q for the period ending Sep 26, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Feb 4
Estimated date · Time not announced
Reported EPS
$1.00
Quarter ended Sep 2026
Year ago EPS
$0.81
+23.5% on a GAAP basis
Revenue
$357.8M
+9.3% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.74Dec '24Mar 2025: $1.17Mar '25Jun 2025: $0.70Jun '25Sep 2025: $0.81Sep '25Dec 2025: $0.95Dec '25Mar 2026: -$0.41Mar '26Jun 2026: $0.72Jun '26Sep 2026: $1.00Sep '26Latest $1.00
Revenue by quarter
Dec 2024: $348.5MDec '24Mar 2025: $330.6MMar '25Jun 2025: $321.4MJun '25Sep 2025: $327.3MSep '25Dec 2025: $339.0MDec '25Mar 2026: $346.4MMar '26Jun 2026: $339.4MJun '26Sep 2026: $357.8MSep '26Latest $357.8M
How HAE moved after its last 8 reports
Average move the session after a report ±10.7%
Nov 5, 2026Time not announced−2.6%
Aug 6, 2026Time not announced+1.7%
May 7, 2026Time not announced+3.2%
Feb 5, 2026Time not announced−1.4%
Nov 6, 2025Time not announced+32.3%
Aug 7, 2025Time not announced−26.6%
May 8, 2025Time not announced+5.8%
Feb 6, 2025Time not announced−11.6%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on HAEStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on HAE
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on HAE

Technical Analysis

HAE · as of the Nov 20 close · updated each morning
Uptrend

The stock sits between its 20 and 50 day averages. It is 31% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 52). The nearest support is the Pivot S1 at $119.11, and the nearest resistance the Pivot at $120.73.

Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 3.4%/day
Key levels
$132.0052 week high+9.9%
$121.91Swing high (Oct 27)+1.5%
$121.77Pivot R1+1.3%
$121.0620 day average+0.7%
$120.73Pivot+0.5%
$120.16Last close
$119.11Pivot S1−0.9%
$116.68Swing low (Nov 10)−2.9%
$115.1750 day average−4.2%
$102.53100 day average−14.7%
$82.65200 day average−31.2%
$51.0052 week low−57.6%
Indicators
RSI (14)51.92Middle of its rangeNeutral
MACD1.66Below its signal lineBearish
Stochastic29.1Middle of its rangeNeutral
ADX (14)37.4Trending up
Williams %R-77.3Oversold below −80, overbought above −20Neutral
CCI (20)-19.6Oversold below −100, overbought above 100Neutral
Rate of change+0.2%Change over 10 sessionsBullish
ATR (14)$4.09Typical daily range, 3.4% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for HAE

What happened before

See how HAE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow HAE usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How HAE has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for HAEHow many large options trades hit HAE, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

HAE Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●176 buying vs 170 selling
  • ▼Held by funds -0.7 pts
  • ▲Funds holding +29
  • ▲Superinvestors: 5 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding361332+8.7%
In funds' top 1062+200.0%
Held by funds108.3%109.1%−0.7 pts
New / increased64 / 11255 / 108+8.0%
Reduced / sold out135 / 35119 / 46+3.0%
Put/call ratio0.880.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See HAE institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

HAE Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$101K1 sale · 1 insider
2026-11 sold $101KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 11Farris Maryanne MaunsellVP, Chief Accounting OfficerSale836$120.99$101K
Nov 10, 2025Mark W KrollDirectorBuy1,400$70.56$99K
Every insider buy and sale for HAE over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See HAE insider trades →

From SEC Form 4 filings by HAE's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HAE is in one of them and how their past HAE trades turned out.

HAE in the AI portfolios
Loading…

HAE News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered HAE in an article yet. Here's the latest on the wider market.

HAE in the news

HAE Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed May 25
Who traded HAE · since 2018
Latest 5 filings of 13
$1K – $15KTraded May 7, 2021Filed May 25, 2021
Lois FrankelSell (partial)
$1K – $15KTraded May 6, 2021Filed May 25, 2021
$1K – $15KTraded Jan 25, 2021Filed Feb 9, 2021
$1K – $15KTraded Oct 16, 2020Filed Nov 5, 2020
Josh GottheimerSell (partial)
$1K – $15KTraded Sep 15, 2020Filed Oct 13, 2020
PersonTypeAmountTradedFiledDelay
Lois FrankelD · FLSell$1K – $15KMay 7, 2021May 25, 202118 d
Lois FrankelD · FLSell (partial)$1K – $15KMay 6, 2021May 25, 202119 d
Josh GottheimerD · NJSell$1K – $15KJan 25, 2021Feb 9, 202115 d
Josh GottheimerD · NJBuy$1K – $15KOct 16, 2020Nov 5, 202020 d
Josh GottheimerD · NJSell (partial)$1K – $15KSep 15, 2020Oct 13, 202028 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Haemonetics

Haemonetics is a medical technology company based in Massachusetts. It makes automated plasma collection systems, donor management software and related disposables for plasma collection centers, mainly those that gather plasma for pharmaceutical makers. It also sells blood collection and processing equipment to blood centers, and surgical and blood management products such as vascular closure devices and cell salvage systems to hospitals.

Headquarters
Boston, MA
Founded
1971